Development of drug treatments for neurofibromatosis type 2-associated vestibular schwannoma. [electronic resource]
Producer: 20130131Description: 372-9 p. digitalISSN:- 1531-6998
- Angiogenesis Inhibitors -- pharmacology
- Clinical Trials as Topic
- Female
- Follow-Up Studies
- Forecasting
- Humans
- Male
- Molecular Targeted Therapy -- methods
- Neovascularization, Pathologic -- prevention & control
- Neurofibromatosis 2 -- drug therapy
- Neurofibromin 2 -- drug effects
- Neuroma, Acoustic -- drug therapy
- Risk Assessment
- TOR Serine-Threonine Kinases -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.